THE INNOVATIVE MEDICINES INITIATIVE
The Innovative Medicines Initiative (IMI) is Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients.
IMI supports collaborative research projects and builds networks of industrial and academic experts in order to boost pharmaceutical innovation in Europe.
IMI is a joint undertaking between the European Union and the pharmaceutical industry association EFPIA.
IMI enters new phase with €3.3 billion budget
IMI enters its second phase with a €3.3 billion budget & the ambitious goal of fast-tracking the development of the next generation of medicines, especially in areas of unmet need.
- 23/07/2014 : RT @LillyPadEU: Public-private partnerships like @IMI_JU are about joining forces to make the lives better http://t.co/eRJfHwLD2F #healthy…
- 17/07/2014 : RT @Eu2P: Meet Eu2P trainers, classmates & the office team: #Eu2PFW Sep 24-26 in Bordeaux http://t.co/PI6fNFuRyL @cgfbordeaux http://t.co/D…
- 17/07/2014 : ALL call documents for IMI 2 - Call 1 are online at http://t.co/Kn39KbuMkQ Our e-mail address is email@example.com